Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2324182
Max Phase: Preclinical
Molecular Formula: C18H26N2
Molecular Weight: 270.42
Molecule Type: Small molecule
Associated Items:
ID: ALA2324182
Max Phase: Preclinical
Molecular Formula: C18H26N2
Molecular Weight: 270.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCc1ccc(CNC23CC4CC(CC(C4)C2)C3)cc1
Standard InChI: InChI=1S/C18H26N2/c19-11-13-1-3-14(4-2-13)12-20-18-8-15-5-16(9-18)7-17(6-15)10-18/h1-4,15-17,20H,5-12,19H2
Standard InChI Key: DXMDPRFUKQLCHD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 270.42 | Molecular Weight (Monoisotopic): 270.2096 | AlogP: 3.20 | #Rotatable Bonds: 4 |
Polar Surface Area: 38.05 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.06 | CX LogP: 2.75 | CX LogD: -1.56 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.88 | Np Likeness Score: -0.43 |
1. Wang J, Ma C, Wang J, Jo H, Canturk B, Fiorin G, Pinto LH, Lamb RA, Klein ML, DeGrado WF.. (2013) Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus., 56 (7): [PMID:23437766] [10.1021/jm301538e] |
Source(1):